Methylene Blue Injection/Open Joint Evaluation
INDICATIONS
When there is clinical suspicion of communication between a traumatic wound and joint space
When intra-articular air within the joint space is seen on radiographs
CONTRAINDICATIONS
Evidence of overlying cellulitis on the site of arthrocentesis
Patients taking serotonergic psychiatric drugs (risk of serotonin syndrome) and those having glucose-6-phosphate dehydrogenase deficiency (risk of anemia and methemoglobinemia) (FIGURE 49.1)
RISKS/CONSENT ISSUES
Risk of iatrogenic septic arthritis
Risk of iatrogenic hemarthrosis
Allergic reaction to local anesthetic
Pain during and after procedure
LANDMARKS
In most cases approach is via the extensor surface of joints (avoids vessels and nerves)
Specific landmarks should be utilized depending on the joint
If available, ultrasound can be used to facilitate arthrocentesis
TECHNIQUE
Prepare the Methylene Blue Injection
Methylene blue usually comes in 1-mL ampoules. There are no exact dilutional guidelines; we recommend diluting 1 mL of methylene blue with 29 mL normal saline in a 30-mL syringe.
Attach an 18- or 20-gauge needle to the syringe
Prepare the Joint Before Injection
Prepare the skin using either a povidone–iodine solution or a chlorhexidine solution and a large sterile drape
Using a small-gauge needle, deposit a small wheal of either 1% or 2% lidocaine for local anesthesia
Inject the Joint
Enter the joint space using standard arthrocentesis technique
Inject the methylene blue solution into the affected joint space until the joint is fully distended or methylene blue exudes from the wound
The amount of solution necessary to fully distend the joint is mostly dependent on the joint in question
The shoulder can hold ∼30 mL and the knee can hold approximately 60 mL
Studies support injecting up to the maximum tolerated volume of the joint or until fluid begins to extravasate through the wound
A positive test is considered if any extravasation of fluid is seen from the wound